LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Clinical trials for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL trials appear
Sign up with your email to follow new studies for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy for leukemia tested in routine care
Disease control Recruiting nowThis study looks at how well a combination of two drugs, ibrutinib and venetoclax, works for people with chronic lymphocytic leukemia (CLL) when used in regular medical practice. About 60 adults who need treatment for CLL will take these pills for a set period of time. The main g…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 07:35 UTC
-
New hope for Tough-to-Treat blood cancer: drug combo aims to keep disease in check
Disease control Recruiting nowThis study tests whether a new drug, nemtabrutinib, combined with venetoclax works better than the standard venetoclax plus rituximab for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or not responded to at least one prior t…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
Can personalized dosing make CLL treatment safer and more effective?
Disease control Recruiting nowThis study tests two approaches for people with untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma: a combination of ibrutinib and venetoclax, or ibrutinib alone. The key idea is to adjust the ibrutinib dose—either by starting lower or changing it based on…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
Engineered immune cells take on Hard-to-Treat blood cancers
Disease control Recruiting nowThis study tests a treatment called JCAR017, made from a patient's own immune cells that are reprogrammed to attack cancer. It is for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or not responded to other treatments. The st…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE1, PHASE2 • Sponsor: Juno Therapeutics, a Subsidiary of Celgene • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
Engineered immune cells take aim at Hard-to-Treat leukemias
Disease control Recruiting nowThis study tests a treatment called CAR T-cell therapy for people with advanced B-cell leukemias or lymphomas that haven't responded to standard drugs. Participants' own immune cells are collected, modified in a lab to recognize and attack cancer cells, and then returned to the b…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Exercise boosts Well-Being in leukemia patients on targeted therapy
Symptom relief Recruiting nowThis study looks at whether a tailored physical activity plan can help people with chronic lymphocytic leukemia (CLL) feel better while taking the drug ibrutinib. About 180 participants will be followed for up to 12 months to measure changes in their quality of life, including ph…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Sponsor: Janssen Cilag S.A.S. • Aim: Symptom relief
Last updated May 22, 2026 13:52 UTC
-
Can your genes predict blood cancer? mayo clinic launches massive family study
Knowledge-focused Recruiting nowThis study looks at why some families have more blood cancers like lymphoma, leukemia, and myeloma. Researchers will study the genes and environment of 3000 people who have at least two living relatives with these cancers. The goal is to find inherited factors that raise risk, no…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 04, 2026 16:31 UTC